152 related articles for article (PubMed ID: 25739391)
41. Orthotopic hepatocellular carcinoma: molecular imaging-monitored intratumoral hyperthermia-enhanced direct oncolytic virotherapy.
Song J; Zhang F; Ji J; Chen M; Li Q; Weng Q; Gu S; Kogut MJ; Yang X
Int J Hyperthermia; 2019; 36(1):344-350. PubMed ID: 30776922
[TBL] [Abstract][Full Text] [Related]
42. Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice.
Wei D; Li Q; Wang XL; Wang Y; Xu J; Feng F; Nan G; Wang B; Li C; Guo T; Chen ZN; Bian H
J Exp Clin Cancer Res; 2015 Dec; 34():153. PubMed ID: 26689432
[TBL] [Abstract][Full Text] [Related]
43. Respiratory Syncytial Virus Replication Is Promoted by Autophagy-Mediated Inhibition of Apoptosis.
Li M; Li J; Zeng R; Yang J; Liu J; Zhang Z; Song X; Yao Z; Ma C; Li W; Wang K; Wei L
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386287
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of the IFN-beta response in hepatocellular carcinoma by alternative spliced isoform of IFN regulatory factor-3.
Marozin S; Altomonte J; Stadler F; Thasler WE; Schmid RM; Ebert O
Mol Ther; 2008 Nov; 16(11):1789-97. PubMed ID: 18781139
[TBL] [Abstract][Full Text] [Related]
45. Targeting gene-virus-mediated manganese superoxide dismutase effectively suppresses tumor growth in hepatocellular carcinoma in vitro and in vivo.
Huang F; Ma B; Wang Y; Xiao R; Kong Y; Zhou X; Xia D
Cancer Biother Radiopharm; 2014 Dec; 29(10):403-11. PubMed ID: 25414976
[TBL] [Abstract][Full Text] [Related]
46. The cytotoxic effect of E1B 55-kDa mutant adenovirus on human hepatocellular carcinoma cell lines.
Zhao J; Wang H; Wei L; Habib NA; Lu X; Wu M; Guo Y
Cancer Gene Ther; 2001 May; 8(5):333-41. PubMed ID: 11477453
[TBL] [Abstract][Full Text] [Related]
47. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
[TBL] [Abstract][Full Text] [Related]
48. Synergistic Anti-tumour Effects of Quercetin and Oncolytic Adenovirus expressing TRAIL in Human Hepatocellular Carcinoma.
Zou H; Zheng YF; Ge W; Wang SB; Mou XZ
Sci Rep; 2018 Feb; 8(1):2182. PubMed ID: 29391509
[TBL] [Abstract][Full Text] [Related]
49. Oncolytic vaccinia virus inhibits human hepatocellular carcinoma MHCC97-H cell proliferation via endoplasmic reticulum stress, autophagy and Wnt pathways.
Jia X; Chen Y; Zhao X; Lv C; Yan J
J Gene Med; 2016 Sep; 18(9):211-9. PubMed ID: 27441866
[TBL] [Abstract][Full Text] [Related]
50. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
[TBL] [Abstract][Full Text] [Related]
51. Differential sensitivity of hepatocellular carcinoma cells to suppression of hepatocystin transcription under hypoxic conditions.
Yoo JJ; Lee DH; Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
J Bioenerg Biomembr; 2016 Dec; 48(6):581-590. PubMed ID: 27640193
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic Efficacy of an Oncolytic Influenza Virus Carrying an Antibody Against Programmed Cell Death 1 in Hepatocellular Carcinoma.
Lei G; Li B; Yang H; Sun F; Li D; Yan J; Wang Y; Li R; Liu H; Zhang S; Li Y; Yang P
Hum Gene Ther; 2022 Mar; 33(5-6):309-317. PubMed ID: 35018832
[TBL] [Abstract][Full Text] [Related]
53. Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.
You ML; Chen YJ; Chong QY; Wu MM; Pandey V; Chen RM; Liu L; Ma L; Wu ZS; Zhu T; Lobie PE
Oncotarget; 2017 Jun; 8(24):39323-39344. PubMed ID: 28445151
[TBL] [Abstract][Full Text] [Related]
54. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
[TBL] [Abstract][Full Text] [Related]
55. Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1.
Wirth T; Kühnel F; Fleischmann-Mundt B; Woller N; Djojosubroto M; Rudolph KL; Manns M; Zender L; Kubicka S
Cancer Res; 2005 Aug; 65(16):7393-402. PubMed ID: 16103092
[TBL] [Abstract][Full Text] [Related]
56. The antitumor effect of oncolytic respiratory syncytial virus via the tumor necrosis factor-alpha induction and ROS-bax-mediated mechanisms.
Samadi M; Mokhtari-Azad T; Nejati A; Norooz-Babaei Z; Foroushani AR; Haghshenas MR; Adjaminejad F; Zargaran H; Salimi V; Ghaemi A
BMC Cancer; 2023 Aug; 23(1):803. PubMed ID: 37641004
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of respiratory syncytial virus replication and virus-induced p38 kinase activity by berberine.
Shin HB; Choi MS; Yi CM; Lee J; Kim NJ; Inn KS
Int Immunopharmacol; 2015 Jul; 27(1):65-8. PubMed ID: 25939536
[TBL] [Abstract][Full Text] [Related]
58. Oncolytic vesicular stomatitis virus for treatment of orthotopic hepatocellular carcinoma in immune-competent rats.
Ebert O; Shinozaki K; Huang TG; Savontaus MJ; García-Sastre A; Woo SL
Cancer Res; 2003 Jul; 63(13):3605-11. PubMed ID: 12839948
[TBL] [Abstract][Full Text] [Related]
59. Exploring the role of oncolytic viruses in hepatobiliary cancers.
Tenneti P; Borad MJ; Babiker HM
Immunotherapy; 2018 Aug; 10(11):971-986. PubMed ID: 29900755
[TBL] [Abstract][Full Text] [Related]
60. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
Yang F; Lv LZ; Cai QC; Jiang Y
World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
